1. Home
  2. AURA vs RWAY Comparison

AURA vs RWAY Comparison

Compare AURA & RWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • RWAY
  • Stock Information
  • Founded
  • AURA 2007
  • RWAY 2015
  • Country
  • AURA United States
  • RWAY United States
  • Employees
  • AURA N/A
  • RWAY N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • RWAY
  • Sector
  • AURA Health Care
  • RWAY
  • Exchange
  • AURA Nasdaq
  • RWAY Nasdaq
  • Market Cap
  • AURA 396.8M
  • RWAY 410.4M
  • IPO Year
  • AURA 2021
  • RWAY 2021
  • Fundamental
  • Price
  • AURA $6.37
  • RWAY $10.14
  • Analyst Decision
  • AURA Strong Buy
  • RWAY Buy
  • Analyst Count
  • AURA 5
  • RWAY 6
  • Target Price
  • AURA $21.80
  • RWAY $11.17
  • AVG Volume (30 Days)
  • AURA 294.2K
  • RWAY 285.8K
  • Earning Date
  • AURA 11-13-2025
  • RWAY 11-06-2025
  • Dividend Yield
  • AURA N/A
  • RWAY 13.81%
  • EPS Growth
  • AURA N/A
  • RWAY 153.06
  • EPS
  • AURA N/A
  • RWAY 1.91
  • Revenue
  • AURA N/A
  • RWAY $140,975,000.00
  • Revenue This Year
  • AURA N/A
  • RWAY N/A
  • Revenue Next Year
  • AURA N/A
  • RWAY N/A
  • P/E Ratio
  • AURA N/A
  • RWAY $5.30
  • Revenue Growth
  • AURA N/A
  • RWAY N/A
  • 52 Week Low
  • AURA $4.35
  • RWAY $8.35
  • 52 Week High
  • AURA $11.33
  • RWAY $11.73
  • Technical
  • Relative Strength Index (RSI)
  • AURA 55.74
  • RWAY 53.96
  • Support Level
  • AURA $5.62
  • RWAY $9.66
  • Resistance Level
  • AURA $6.16
  • RWAY $9.99
  • Average True Range (ATR)
  • AURA 0.36
  • RWAY 0.20
  • MACD
  • AURA 0.03
  • RWAY 0.06
  • Stochastic Oscillator
  • AURA 76.46
  • RWAY 90.74

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About RWAY Runway Growth Finance Corp.

Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and UK, Canada, Netherlands, with the majority of its portfolio invested in the United States.

Share on Social Networks: